Kura Oncology, Inc. (KURA)

Kura Oncology Revenue

Kura Oncology had revenue of $18.27M in the quarter ending March 31, 2026, with 29.47% growth. This brings the company's revenue in the last twelve months to $71.64M, up 5.37% year-over-year. In the year 2025, Kura Oncology had annual revenue of $67.48M with 25.24% growth.

• Revenue (ttm): $71.64M
• Revenue Growth: +5.37%
• P/S Ratio: 12.31
• Revenue / Employee: $275,535
• Employees: 260
• Market Cap: 881.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.48M	13.60M	25.24%
Dec 31, 2024	53.88M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error